Dr. Ilya Nasrallah, MD, PhD
Claim this profileUniversity of Pennsylvania
Studies Tauopathies
Studies Opioid Dependence
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Ilya Nasrallah, MD, PhD is currently running
Tau PET Imaging
for Opioid Use Disorder
The investigators plan to enroll up to 60 adult subjects in this study. There will be three groups of up to 20 subjects each in this study. Group 1: individuals with OUD and a history of at least one opioid-related OD in the past 5 years that required naloxone treatment reversal: OUD/OD+ Group 2: individuals with OUD without a lifetime history of opioid-related OD OUD/OD- Group 3: Healthy controls without a lifetime OUD: HCs PET/CT imaging will be used to evaluate the uptake of tau in the brain using the investigational radiotracer \[18F\]PI-2620. Each subject will have one \[18F\]PI-2620 positron emission tomography/computed tomography (PET/CT) scan performed.
Recruiting1 award Phase < 1
Diagnostic Imaging
for Tauopathies
This current protocol will provide the key data to help determine the specificity of our to-be-developed radiotracers by implementing a multi-site diagnostic assessment core and PET imaging of A-beta amyloid (may be completed at some sites as part of another protocol) that is commonly deposited in the brains of people with Parkinson's Disease (PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) or Frontotemporal Dementia (FTD) as well as healthy controls. This multicenter U19 grant is centered at U Pennsylvania (U Penn) (PI: Robert Mach) in collaboration with U Pittsburgh (Pitt), Yale University, U of California at San Francisco (UCSF) and Washington University in St. Louis (WU). U Penn will act as the single IRB of Record (sIRB) for this multi-center project and subjects will be recruited from all sites.
Recruiting1 award N/A5 criteria
More about Ilya Nasrallah, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ilya Nasrallah, MD, PhD has experience with
- 18F-PI-2620 PET/CT
- 11C-M503
- Amyloid PET Scan
- Brain MRI Scan
- Neurologic Exam
- 11C-HY-2-15
Breakdown of trials Ilya Nasrallah, MD, PhD has run
Tauopathies
Opioid Dependence
Opioid Use Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ilya Nasrallah, MD, PhD specialize in?
Ilya Nasrallah, MD, PhD focuses on Tauopathies and Opioid Dependence. In particular, much of their work with Tauopathies has involved treating patients, or patients who are undergoing treatment.
Is Ilya Nasrallah, MD, PhD currently recruiting for clinical trials?
Yes, Ilya Nasrallah, MD, PhD is currently recruiting for 4 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Ilya Nasrallah, MD, PhD has studied deeply?
Yes, Ilya Nasrallah, MD, PhD has studied treatments such as 18F-PI-2620 PET/CT, 11C-M503, Amyloid PET scan.
What is the best way to schedule an appointment with Ilya Nasrallah, MD, PhD?
Apply for one of the trials that Ilya Nasrallah, MD, PhD is conducting.
What is the office address of Ilya Nasrallah, MD, PhD?
The office of Ilya Nasrallah, MD, PhD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.